Sava Infond d.o.o. »

BioMarin Pharmaceutical shares owned by Sava Infond d.o.o.

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Sava Infond d.o.o. from 13F filings

Historical chart of Sava Infond d.o.o. investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Sava Infond d.o.o. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Sava Infond d.o.o.

Quarter filed Position value Share count Share price at filing
2025-09-30 $176k 3.3k 54.16
2025-06-30 $179k 3.3k 54.97
2025-03-31 $230k 3.3k 70.69

More positions owned by Sava Infond d.o.o.

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Servicenow (NOW)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Palo Alto Networks (PANW)
salesforce (CRM)
Marvell Technology (MRVL)
Applied Materials (AMAT)
MercadoLibre (MELI)

View all positions for Sava Infond d.o.o.

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical